DBT: Selling shares of CDP

The Board resolution dated March 21, 2023, BenTre Pharmaceutical Joint Stock Company approved to sell 4,226,950 shares of CDP. Accordingly, CDP will no longer be an associated company with Codupha Central Pharmaceutical JSC.

-          Estimated trading period: from March 22, 2023 to April 22, 2023

-          Trading method: order matching or put through.

HOSE

>   BAF: Approving the transaction with related parties in 2023 (23/03/2023)

>   ADS: Report on Outstanding Voting Shares (23/03/2023)

>   TIX: TIX signs an Auditing Contract (23/03/2023)

>   SJS: Reminder of information disclosure (23/03/2023)

>   HSL: Adjustment of stock type (23/03/2023)

>   AMD: Holding EGM 2023 (23/03/2023)

>   NVL: BOD resolution dated March 21, 2023 (23/03/2023)

>   NVL: Notice of Authorized Person to disclose information (23/03/2023)

>   TCM: Approving the transaction with related parties (23/03/2023)

>   HBC: Report on results of trading of shares by Related Person - Nguyen Thi Xuan Lan (23/03/2023)